SARS-CoV-2 pandemic as a model to assess the relationship between intercurrent viral infections and disease activity in Multiple Sclerosis: A propensity score matched case-control study

[1]  Hafsa Z. Zuberi,et al.  Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: Onset Following Acute COVID-19 Infection, a Case Series , 2022, Neurology and Therapy.

[2]  S. Nishiyama,et al.  COVID-19 and the risk of CNS demyelinating diseases: A systematic review , 2022, Frontiers in Neurology.

[3]  Jae-Won Hyun,et al.  Onset of various CNS inflammatory demyelination diseases following COVID-19 vaccinations , 2022, Multiple Sclerosis and Related Disorders.

[4]  C. Enzinger,et al.  Long‐term outcome after COVID‐19 infection in multiple sclerosis: A nation‐wide multicenter matched‐control study , 2022, European journal of neurology.

[5]  B. Healy,et al.  COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders , 2022, Multiple sclerosis and related disorders.

[6]  Manal M. Badawi,et al.  The disease course of multiple sclerosis before and during COVID-19 pandemic: A retrospective five-year study , 2022, Multiple Sclerosis and Related Disorders.

[7]  M. Etemadifar,et al.  Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study , 2022, BMC Neurology.

[8]  O. Garcea,et al.  ¿ Can COVID-19 exacerbate multiple sclerosis symptoms? A case series analysis. , 2021, Multiple sclerosis and related disorders.

[9]  I. Ismail,et al.  Association of CNS demyelination and COVID-19 infection: an updated systematic review , 2021, Journal of Neurology.

[10]  Shuyang Zhang,et al.  The Epidemiology of COVID-19 and MS-Related Characteristics in a National Sample of People With MS in China , 2021, Frontiers in Neurology.

[11]  M. Duddy,et al.  COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies , 2021, Multiple Sclerosis and Related Disorders.

[12]  V. Shaygannejad,et al.  Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study , 2021, Multiple Sclerosis and Related Disorders.

[13]  M. Etemadifar,et al.  COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect? , 2021, Multiple Sclerosis and Related Disorders.

[14]  F. Yavari,et al.  Demyelinating Changes Alike to Multiple Sclerosis: A Case Report of Rare Manifestations of COVID-19 , 2020, Case reports in neurological medicine.

[15]  L. C. Hygino da Cruz,et al.  COVID-19 associated with encephalomyeloradiculitis and positive anti-aquaporin-4 antibodies: Cause or coincidence? , 2020, Multiple sclerosis.

[16]  H. D. De Cauwer,et al.  Neurological manifestations of COVID-19, SARS and MERS , 2020, Acta Neurologica Belgica.

[17]  G. Angelini,et al.  Statistical primer: propensity score matching and its alternatives† , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18]  A. Steelman,et al.  Infection as an Environmental Trigger of Multiple Sclerosis Disease Exacerbation , 2015, Front. Immunol..

[19]  J. Correale,et al.  The risk of relapses in multiple sclerosis during systemic infections , 2006, Neurology.

[20]  H. Panitch.  Influence of infection on exacerbations of multiple sclerosis , 2004, Annals of neurology.

[21]  W. Hop,et al.  Prospective study on the relationship between infections and multiple sclerosis exacerbations. , 2002, Brain : a journal of neurology.

[22]  J. Keyser,et al.  Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis , 1998, Journal of the Neurological Sciences.

[23]  L. Blumhardt,et al.  Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis , 1998, Journal of neurology, neurosurgery, and psychiatry.

[24]  T. Bergström,et al.  Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study , 1993, Journal of Neurology.

[25]  W. Sibley,et al.  CLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSIS , 1985, The Lancet.